Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jeffrey J. Everly"'
Publikováno v:
Behavior Analysis: Research and Practice. 17:114-128
Chronically unemployed adults may benefit from intensive job-skills training; however, training programs do not always reliably engage participants in mastering skills. This study examined effects of voucher reinforcement for performance on a job-ski
Autor:
Brantley P. Jarvis, Michael Fingerhood, Kenneth Silverman, August F. Holtyn, Jeannie Marie S. Leoutsakos, George E. Bigelow, Jeffrey J. Everly, Kelly E. Dunn, Anthony DeFulio, Annie Umbricht
Publikováno v:
Addiction. 112:830-837
Aim To test whether an incentive-based intervention that increased adherence to naltrexone also increased opiate abstinence. Design Post-hoc combined analysis of three earlier randomized controlled trials that showed individually that incentives for
Autor:
Jeffrey J. Everly
Publikováno v:
The Psychological Record. 66:139-151
Ten human participants worked on a computer-based discrete-trials signal detection task in which stimulus disparity and the ratio of reinforcers for correct responses were manipulated. During each trial, a 12 × 12 stimulus array consisting of an une
Autor:
Michael Fingerhood, Annie Umbricht, Kelly E. Dunn, Kenneth Silverman, George E. Bigelow, Will M. Aklin, Jeannie Marie S. Leoutsakos, Paul A. Nuzzo, Jeffrey J. Everly, Wendy D. Donlin, Anthony DeFulio
Publikováno v:
Experimental and Clinical Psychopharmacology. 21:74-83
Naltrexone has high potential for use as a relapse prevention pharmacotherapy for opiate dependence; however suffers from notoriously poor adherence when prescribed for oral self-administration. This study evaluated whether entry to a therapeutic wor
Autor:
George E. Bigelow, Annie Umbricht, Jeannie Marie S. Leoutsakos, Jeffrey J. Everly, Kenneth Silverman, Anthony DeFulio, Michael Fingerhood
Publikováno v:
Drug and Alcohol Dependence. 120:48-54
Naltrexone provides excellent opioid blockade, but its clinical utility is limited because opioid-dependent patients typically refuse it. An injectable suspension of naltrexone for extended release (XR-NTX) was recently approved by the FDA for treatm
Autor:
George E. Bigelow, Will M. Aklin, Mikhail N. Koffarnus, Annie Umbricht, Michael Fingerhood, Jeffrey J. Everly, Anthony DeFulio, Kenneth Silverman, Wendy D. Donlin, Jeannie Marie S. Leoutsakos
Publikováno v:
Addiction. 106:1309-1318
Aims Naltrexone can be used to treat opioid dependence, but patients refuse to take it. Extended-release depot formulations may improve adherence, but long-term adherence rates to depot naltrexone are not known. This study determined long-term rates
Autor:
Wendy D. Donlin, Jeannie Marie S. Leoutsakos, Paul A. Nuzzo, Anthony DeFulio, George E. Bigelow, Will M. Aklin, Annie Umbricht, Jeffrey J. Everly, Michael Fingerhood, Kelly E. Dunn, Kenneth Silverman
Oral naltrexone could be a promising relapse-prevention pharmacotherapy for recently detoxified opioid-dependent patients; however, interventions are often needed to promote adherence with this treatment approach. We recently conducted a study to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca10b240f40afaf11df47385f81dc0c
https://europepmc.org/articles/PMC4339630/
https://europepmc.org/articles/PMC4339630/